Diabetes Increases the Incidence of Levodopa-Induced Dyskinesia in Parkinson’s Disease; A Case-Control Study | Zendy

Marzieh Mirzae | Zendy; Mohammad Hossein Abbasi | Zendy; Gholam Ali Shahidi | Zendy; Qodsiye Hosseinifakhr | Zendy; Farzad Sina | Zendy; Seyed Amirhassan Habibi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Diabetes Increases the Incidence of Levodopa-Induced Dyskinesia in Parkinson’s Disease; A Case-Control Study

Author(s) -

Marzieh Mirzae,

Mohammad Hossein Abbasi,

Gholam Ali Shahidi,

Qodsiye Hosseinifakhr,

Farzad Sina,

Seyed Amirhassan Habibi

Publication year - 2021

Publication title -

journal of advances in medical and biomedical research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.113

H-Index - 12

ISSN - 2676-6264

DOI - 10.30699/jambs.29.136.257

Subject(s) - dyskinesia , parkinson's disease , incidence (geometry) , levodopa , medicine , disease , diabetes mellitus , pediatrics , physical medicine and rehabilitation , endocrinology , physics , optics

Parkinson’s disease (PD) is a systemic neurodegenerative disorder, affecting dopaminergic interactions inside the basal ganglia; finally, it results in an intermittent transfer of unwanted stimulatory signals into the corticospinal tract and disease manifestations. The corticospinal tract is the final affected portion of dopaminergic neurons through inhibition or stimulation of thalamic stimulatory signals to the motor cortex as a result of basal ganglia neuronal interactions (1-3).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research